+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Intravenous Iron Drugs Market by Drug Type, Indication, End User, Distribution Channel, Patient Age Group - Global Forecast to 2030- Product Image
Intravenous Iron Drugs Market by Drug Type, Indication, End User, Distribution Channel, Patient Age Group - Global Forecast to 2030- Product Image
Sale

Intravenous Iron Drugs Market by Drug Type, Indication, End User, Distribution Channel, Patient Age Group - Global Forecast to 2030

  • PDF Icon

    Report

  • 199 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5454933
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The intravenous iron drugs market is advancing rapidly, shaped by innovative therapies, expanding patient needs, and global strategies focused on healthcare efficiency. Decision-makers face a transformed environment requiring an integrated view of evolving clinical, regulatory, and supply chain trends in intravenous iron administration.

Market Snapshot: Intravenous Iron Drugs Market Overview

The intravenous iron drugs market grew from USD 3.16 billion in 2024 to USD 3.47 billion in 2025 and is projected to expand at a CAGR of 9.68%, reaching USD 5.51 billion by 2030. Rising global prevalence of iron deficiency—especially in patients managing chronic conditions such as renal disease and oncology—continues to drive the demand for effective intravenous solutions. This growth trajectory reflects uptake in both established and emerging markets, increased adoption in ambulatory care, and a shift to digital monitoring tools supporting patient safety and adherence.

Scope & Segmentation Across the Intravenous Iron Drugs Market

This research delivers actionable insights into the structure and dynamics of the intravenous iron space:

  • Drug Types: Ferric Carboxymaltose, Ferumoxytol, Iron Dextran, Iron Isomaltoside, Iron Sucrose
  • Indications: Cancer-Associated Anemia, Chronic Kidney Disease (hemodialysis, peritoneal dialysis, predialysis), Iron Deficiency Anemia, Pregnancy-Related Anemia (first to third trimester)
  • End Users: Dialysis Centers, Hospitals, Specialty Clinics
  • Distribution Channels: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies
  • Patient Age Groups: Adult, Geriatric, Pediatric
  • Regions Covered: Americas (including the United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (multiple nations), and Asia-Pacific (key countries such as China, India, Japan, Australia, South Korea, and others)
  • Key Technologies: Formulation innovation, nanoparticulate carriers, digital patient monitoring platforms
  • Leading Companies Evaluated: Vifor Pharma Ltd., Luitpold Pharmaceuticals LLC, Pharmacosmos A/S, AMAG Pharmaceuticals Inc., Fresenius Kabi AG, Baxter International Inc., American Regent Inc., Nipro Corporation, Dr. Falk Pharma GmbH, Teva Pharmaceutical Industries Ltd.

Key Takeaways for Senior Decision-Makers

  • Next-generation intravenous iron formulations, such as those leveraging nanoparticulate technology, are elevating tolerability while reducing treatment and administration time, thereby improving patient outcomes and operational efficiency.
  • Collaboration is expanding between pharmaceutical providers, digital health platforms, and specialty service firms, creating a more seamless and patient-centered continuum of care.
  • Supply chains are being reevaluated in favor of regional manufacturing and contract partnerships in response to shifting trade and tariff policies, directly affecting sourcing decisions and pricing resilience.
  • A data-driven understanding of segmented patient needs—including protocols for adult, pediatric, and maternal populations—and end-user priorities in clinics versus hospitals ensures more targeted product development and portfolio expansion.
  • Performance-based payer models are gaining traction, with growing use of real-world evidence and risk-sharing agreements that link revenue to patient outcome metrics rather than purely volume-based sales.
  • Digital health integration supports remote adherence monitoring, safety tracking, and decentralized care models that align with changing patient expectations and healthcare delivery structures.

Tariff Impact on Market Dynamics

In the United States, revised tariff measures introduced in 2025 have increased the cost of imported inputs for intravenous iron drugs, leading to strategic shifts towards localized manufacturing and diversified sourcing partnerships. These changes present both logistical challenges and new opportunities for margin management and supply chain optimization, with organizations pursuing longer-term agreements to stabilize access and minimize tariff-related risks.

Methodology & Data Sources

This report is based on a dual-track approach combining direct interviews with market experts, clinicians, and senior executives, as well as deep secondary research from peer-reviewed publications, corporate filings, and proprietary databases. Cross-referencing and data triangulation techniques were utilized to ensure robust validation and minimize bias in market dynamics assessment.

Why This Report Matters for Strategic Leadership

  • Empowers executives to anticipate market shifts by offering clarity on supply chain models, regulatory frameworks, and emerging regional patterns.
  • Equips leaders with segmentation and technology adoption insights, supporting precise investment planning and risk mitigation in a fragmented and evolving marketplace.
  • Informs resource allocation, product development, and stakeholder collaboration strategies, enhancing operational resilience and competitive positioning.

Conclusion

Effective navigation of the intravenous iron drugs market now demands a blend of innovation, localized operations, and evidence-based, patient-focused strategies. By acting on the insights in this report, senior leaders can unlock long-term growth and ensure superior outcomes across key care segments.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Intravenous Iron Drugs Market, by Drug Type
8.1. Introduction
8.2. Ferric Carboxymaltose
8.3. Ferumoxytol
8.4. Iron Dextran
8.5. Iron Isomaltoside
8.6. Iron Sucrose
9. Intravenous Iron Drugs Market, by Indication
9.1. Introduction
9.2. Cancer-Associated Anemia
9.3. Chronic Kidney Disease
9.3.1. Hemodialysis
9.3.2. Peritoneal Dialysis
9.3.3. Predialysis
9.4. Iron Deficiency Anemia
9.5. Pregnancy-Related Anemia
9.5.1. First Trimester
9.5.2. Second Trimester
9.5.3. Third Trimester
10. Intravenous Iron Drugs Market, by End User
10.1. Introduction
10.2. Dialysis Centers
10.3. Hospitals
10.4. Specialty Clinics
11. Intravenous Iron Drugs Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.3. Online Pharmacies
11.4. Retail Pharmacies
12. Intravenous Iron Drugs Market, by Patient Age Group
12.1. Introduction
12.2. Adult
12.3. Geriatric
12.4. Pediatric
13. Americas Intravenous Iron Drugs Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Intravenous Iron Drugs Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Intravenous Iron Drugs Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Vifor Pharma Ltd.
16.3.2. Luitpold Pharmaceuticals, LLC
16.3.3. Pharmacosmos a/S
16.3.4. AMAG Pharmaceuticals, Inc.
16.3.5. Fresenius Kabi AG
16.3.6. Baxter International Inc.
16.3.7. American Regent, Inc.
16.3.8. Nipro Corporation
16.3.9. Dr. Falk Pharma GmbH
16.3.10. Teva Pharmaceutical Industries Ltd.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. INTRAVENOUS IRON DRUGS MARKET MULTI-CURRENCY
FIGURE 2. INTRAVENOUS IRON DRUGS MARKET MULTI-LANGUAGE
FIGURE 3. INTRAVENOUS IRON DRUGS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2030 (%)
FIGURE 16. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS INTRAVENOUS IRON DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS INTRAVENOUS IRON DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES INTRAVENOUS IRON DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES INTRAVENOUS IRON DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS IRON DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS IRON DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC INTRAVENOUS IRON DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC INTRAVENOUS IRON DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. INTRAVENOUS IRON DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. INTRAVENOUS IRON DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. INTRAVENOUS IRON DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY FERRIC CARBOXYMALTOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY FERUMOXYTOL, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY IRON DEXTRAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY IRON ISOMALTOSIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY IRON SUCROSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY CANCER-ASSOCIATED ANEMIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY HEMODIALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY PERITONEAL DIALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY PREDIALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY IRON DEFICIENCY ANEMIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY PREGNANCY-RELATED ANEMIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY FIRST TRIMESTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY SECOND TRIMESTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY THIRD TRIMESTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY PREGNANCY-RELATED ANEMIA, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY DIALYSIS CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS INTRAVENOUS IRON DRUGS MARKET SIZE, BY PREGNANCY-RELATED ANEMIA, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS INTRAVENOUS IRON DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES INTRAVENOUS IRON DRUGS MARKET SIZE, BY PREGNANCY-RELATED ANEMIA, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES INTRAVENOUS IRON DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 53. CANADA INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 54. CANADA INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 55. CANADA INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2030 (USD MILLION)
TABLE 56. CANADA INTRAVENOUS IRON DRUGS MARKET SIZE, BY PREGNANCY-RELATED ANEMIA, 2018-2030 (USD MILLION)
TABLE 57. CANADA INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. CANADA INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 59. CANADA INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 60. MEXICO INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 61. MEXICO INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 62. MEXICO INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2030 (USD MILLION)
TABLE 63. MEXICO INTRAVENOUS IRON DRUGS MARKET SIZE, BY PREGNANCY-RELATED ANEMIA, 2018-2030 (USD MILLION)
TABLE 64. MEXICO INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. MEXICO INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 66. MEXICO INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL INTRAVENOUS IRON DRUGS MARKET SIZE, BY PREGNANCY-RELATED ANEMIA, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA INTRAVENOUS IRON DRUGS MARKET SIZE, BY PREGNANCY-RELATED ANEMIA, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS IRON DRUGS MARKET SIZE, BY PREGNANCY-RELATED ANEMIA, 2018-2030 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS IRON DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 89. UNITED KINGDOM INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 90. UNITED KINGDOM INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 91. UNITED KINGDOM INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2030 (USD MILLION)
TABLE 92. UNITED KINGDOM INTRAVENOUS IRON DRUGS MARKET SIZE, BY PREGNANCY-RELATED ANEMIA, 2018-2030 (USD MILLION)
TABLE 93. UNITED KINGDOM INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. UNITED KINGDOM INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 95. UNITED KINGDOM INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 96. GERMANY INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 97. GERMANY INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 98. GERMANY INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2030 (USD MILLION)
TABLE 99. GERMANY INTRAVENOUS IRON DRUGS MARKET SIZE, BY PREGNANCY-RELATED ANEMIA, 2018-2030 (USD MILLION)
TABLE 100. GERMANY INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. GERMANY INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 102. GERMANY INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 103. FRANCE INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 104. FRANCE INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 105. FRANCE INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2030 (USD MILLION)
TABLE 106. FRANCE INTRAVENOUS IRON DRUGS MARKET SIZE, BY PREGNANCY-RELATED ANEMIA, 2018-2030 (USD MILLION)
TABLE 107. FRANCE INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. FRANCE INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 109. FRANCE INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 110. RUSSIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 111. RUSSIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 112. RUSSIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2030 (USD MILLION)
TABLE 113. RUSSIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY PREGNANCY-RELATED ANEMIA, 2018-2030 (USD MILLION)
TABLE 114. RUSSIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 115. RUSSIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 116. RUSSIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 117. ITALY INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 118. ITALY INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 119. ITALY INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2030 (USD MILLION)
TABLE 120. ITALY INTRAVENOUS IRON DRUGS MARKET SIZE, BY PREGNANCY-RELATED ANEMIA, 2018-2030 (USD MILLION)
TABLE 121. ITALY INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. ITALY INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 123. ITALY INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 124. SPAIN INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 125. SPAIN INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 126. SPAIN INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2030 (USD MILLION)
TABLE 127. SPAIN INTRAVENOUS IRON DRUGS MARKET SIZE, BY PREGNANCY-RELATED ANEMIA, 2018-2030 (USD MILLION)
TABLE 128. SPAIN INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. SPAIN INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 130. SPAIN INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 131. UNITED ARAB EMIRATES INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 132. UNITED ARAB EMIRATES INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 133. UNITED ARAB EMIRATES INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2030 (USD MILLION)
TABLE 134. UNITED ARAB EMIRATES INTRAVENOUS IRON DRUGS MARKET SIZE, BY PREGNANCY-RELATED ANEMIA, 2018-2030 (USD MILLION)
TABLE 135. UNITED ARAB EMIRATES INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 136. UNITED ARAB EMIRATES INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 137. UNITED ARAB EMIRATES INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 138. SAUDI ARABIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 139. SAUDI ARABIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 140. SAUDI ARABIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2030 (USD MILLION)
TABLE 141. SAUDI ARABIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY PREGNANCY-RELATED ANEMIA, 2018-2030 (USD MILLION)
TABLE 142. SAUDI ARABIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 143. SAUDI ARABIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 144. SAUDI ARABIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 145. SOUTH AFRICA INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 146. SOUTH AFRICA INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 147. SOUTH AFRICA INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2030 (USD MILLION)
TABLE 148. SOUTH AFRICA INTRAVENOUS IRON DRUGS MARKET SIZE, BY PREGNANCY-RELATED ANEMIA, 2018-2030 (USD MILLION)
TABLE 149. SOUTH AFRICA INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. SOUTH AFRICA INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 151. SOUTH AFRICA INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 152. DENMARK INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 153. DENMARK INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 154. DENMARK INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2030 (USD MILLION)
TABLE 155. DENMARK INTRAVENOUS IRON DRUGS MARKET SIZE, BY PREGNANCY-RELATED ANEMIA, 2018-2030 (USD MILLION)
TABLE 156. DENMARK INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. DENMARK INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 158. DENMARK INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 159. NETHERLANDS INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 160. NETHERLANDS INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 161. NETHERLANDS INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2030 (USD MILLION)
TABLE 162. NETHERLANDS INTRAVENOUS IRON DRUGS MARKET SIZE, BY PREGNANCY-RELATED ANEMIA, 2018-2030 (USD MILLION)
TABLE 163. NETHERLANDS INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 164. NETHERLANDS INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 165. NETHERLANDS INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 166. QATAR INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 167. QATAR INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 168. QATAR INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2030 (USD MILLION)
TABLE 169. QATAR INTRAVENOUS IRON DRUGS MARKET SIZE, BY PREGNANCY-RELATED ANEMIA, 2018-2030 (USD MILLION)
TABLE 170. QATAR INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 171. QATAR INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 172. QATAR INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 173. FINLAND INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 174. FINLAND INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 175. FINLAND INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2030 (USD MILLION)
TABLE 176. FINLAND INTRAVENOUS IRON DRUGS MARKET SIZE, BY PREGNANCY-RELATED ANEMIA, 2018-2030 (USD MILLION)
TABLE 177. FINLAND INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 178. FINLAND INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 179. FINLAND INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 180. SWEDEN INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 181. SWEDEN INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 182. SWEDEN INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2030 (USD MILLION)
TABLE 183. SWEDEN INTRAVENOUS IRON DRUGS MARKET SIZE, BY PREGNANCY-RELATED ANEMIA, 2018-2030 (USD MILLION)
TABLE 184. SWEDEN INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. SWEDEN INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 186. SWEDEN INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 187. NIGERIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 188. NIGERIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 189. NIGERIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2030 (USD MILLION)
TABLE 190. NIGERIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY PREGNANCY-RELATED ANEMIA, 2018-2030 (USD MILLION)
TABLE 191. NIGERIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 192. NIGERIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 193. NIGERIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 194. EGYPT INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 195. EGYPT INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 196. EGYPT INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2030 (USD MILLION)
TABLE 197. EGYPT INTRAVENOUS IRON DRUGS MARKET SIZE, BY PREGNANCY-RELATED ANEMIA, 2018-2030 (USD MILLION)
TABLE 198. EGYPT INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 199. EGYPT INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 200. EGYPT INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 201. TURKEY INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 202. TURKEY INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 203. TURKEY INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2030 (USD MILLION)
TABLE 204. TURKEY INTRAVENOUS IRON DRUGS MARKET SIZE, BY PREGNANCY-RELATED ANEMIA, 2018-2030 (USD MILLION)
TABLE 205. TURKEY INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 206. TURKEY INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 207. TURKEY INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 208. ISRAEL INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 209. ISRAEL INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 210. ISRAEL INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2030 (USD MILLION)
TABLE 211. ISRAEL INTRAVENOUS IRON DRUGS MARKET SIZE, BY PREGNANCY-RELATED ANEMIA, 2018-2030 (USD MILLION)
TABLE 212. ISRAEL INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 213. ISRAEL INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 214. ISRAEL INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 215. NORWAY INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 216. NORWAY INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 217. NORWAY INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2030 (USD MILLION)
TABLE 218. NORWAY INTRAVENOUS IRON DRUGS MARKET SIZE, BY PREGNANCY-RELATED ANEMIA, 2018-2030 (USD MILLION)
TABLE 219. NORWAY INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 220. NORWAY INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 221. NORWAY INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 222. POLAND INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 223. POLAND INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 224. POLAND INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2030 (USD MILLION)
TABLE 225. POLAND INTRAVENOUS IRON DRUGS MARKET SIZE, BY PREGNANCY-RELATED ANEMIA, 2018-2030 (USD MILLION)
TABLE 226. POLAND INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 227. POLAND INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 228. POLAND INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 229. SWITZERLAND INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 230. SWITZERLAND INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 231. SWITZERLAND INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2030 (USD MILLION)
TABLE 232. SWITZERLAND INTRAVENOUS IRON DRUGS MARKET SIZE, BY PREGNANCY-RELATED ANEMIA, 2018-2030 (USD MILLION)
TABLE 233. SWITZERLAND INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 234. SWITZERLAND INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 235. SWITZERLAND INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 236. ASIA-PACIFIC INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 237. ASIA-PACIFIC INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 238. ASIA-PACIFIC INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2030 (USD MILLION)
TABLE 239. ASIA-PACIFIC INTRAVENOUS IRON DRUGS MARKET SIZE, BY PREGNANCY-RELATED ANEMIA, 2018-2030 (USD MILLION)
TABLE 240. ASIA-PACIFIC INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 241. ASIA-PACIFIC INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 242. ASIA-PACIFIC INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 243. ASIA-PACIFIC INTRAVENOUS IRON DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 244. CHINA INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 245. CHINA INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 246. CHINA INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2030 (USD MILLION)
TABLE 247. CHINA INTRAVENOUS IRON DRUGS MARKET SIZE, BY PREGNANCY-RELATED ANEMIA, 2018-2030 (USD MILLION)
TABLE 248. CHINA INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 249. CHINA INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 250. CHINA INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 251. INDIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 252. INDIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 253. INDIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2030 (USD MILLION)
TABLE 254. INDIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY PREGNANCY-RELATED ANEMIA, 2018-2030 (USD MILLION)
TABLE 255. INDIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 256. INDIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 257. INDIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 258. JAPAN INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 259. JAPAN INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 260. JAPAN INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2030 (USD MILLION)
TABLE 261. JAPAN INTRAVENOUS IRON DRUGS MARKET SIZE, BY PREGNANCY-RELATED ANEMIA, 2018-2030 (USD MILLION)
TABLE 262. JAPAN INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 263. JAPAN INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 264. JAPAN INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 265. AUSTRALIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 266. AUSTRALIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 267. AUSTRALIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2030 (USD MILLION)
TABLE 268. AUSTRALIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY PREGNANCY-RELATED ANEMIA, 2018-2030 (USD MILLION)
TABLE 269. AUSTRALIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 270. AUSTRALIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 271. AUSTRALIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 272. SOUTH KOREA INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 273. SOUTH KOREA INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 274. SOUTH KOREA INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2030 (USD MILLION)
TABLE 275. SOUTH KOREA INTRAVENOUS IRON DRUGS MARKET SIZE, BY PREGNANCY-RELATED ANEMIA, 2018-2030 (USD MILLION)
TABLE 276. SOUTH KOREA INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 277. SOUTH KOREA INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 278. SOUTH KOREA INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 279. INDONESIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 280. INDONESIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 281. INDONESIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2030 (USD MILLION)
TABLE 282. INDONESIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY PREGNANCY-RELATED ANEMIA, 2018-2030 (USD MILLION)
TABLE 283. INDONESIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 284. INDONESIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 285. INDONESIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 286. THAILAND INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 287. THAILAND INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 288. THAILAND INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2030 (USD MILLION)
TABLE 289. THAILAND INTRAVENOUS IRON DRUGS MARKET SIZE, BY PREGNANCY-RELATED ANEMIA, 2018-2030 (USD MILLION)
TABLE 290. THAILAND INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 291. THAILAND INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 292. THAILAND INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 293. PHILIPPINES INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 294. PHILIPPINES INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 295. PHILIPPINES INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2030 (USD MILLION)
TABLE 296. PHILIPPINES INTRAVENOUS IRON DRUGS MARKET SIZE, BY PREGNANCY-RELATED ANEMIA, 2018-2030 (USD MILLION)
TABLE 297. PHILIPPINES INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 298. PHILIPPINES INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 299. PHILIPPINES INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 300. MALAYSIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 301. MALAYSIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 302. MALAYSIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2030 (USD MILLION)
TABLE 303. MALAYSIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY PREGNANCY-RELATED ANEMIA, 2018-2030 (USD MILLION)
TABLE 304. MALAYSIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 305. MALAYSIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 306. MALAYSIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 307. SINGAPORE INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 308. SINGAPORE INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 309. SINGAPORE INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2030 (USD MILLION)
TABLE 310. SINGAPORE INTRAVENOUS IRON DRUGS MARKET SIZE, BY PREGNANCY-RELATED ANEMIA, 2018-2030 (USD MILLION)
TABLE 311. SINGAPORE INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 312. SINGAPORE INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 313. SINGAPORE INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 314. VIETNAM INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 315. VIETNAM INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 316. VIETNAM INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2030 (USD MILLION)
TABLE 317. VIETNAM INTRAVENOUS IRON DRUGS MARKET SIZE, BY PREGNANCY-RELATED ANEMIA, 2018-2030 (USD MILLION)
TABLE 318. VIETNAM INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 319. VIETNAM INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 320. VIETNAM INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 321. TAIWAN INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 322. TAIWAN INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 323. TAIWAN INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2030 (USD MILLION)
TABLE 324. TAIWAN INTRAVENOUS IRON DRUGS MARKET SIZE, BY PREGNANCY-RELATED ANEMIA, 2018-2030 (USD MILLION)
TABLE 325

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Intravenous Iron Drugs market report include:
  • Vifor Pharma Ltd.
  • Luitpold Pharmaceuticals, LLC
  • Pharmacosmos A/S
  • AMAG Pharmaceuticals, Inc.
  • Fresenius Kabi AG
  • Baxter International Inc.
  • American Regent, Inc.
  • Nipro Corporation
  • Dr. Falk Pharma GmbH
  • Teva Pharmaceutical Industries Ltd.

Table Information

Report AttributeDetails
No. of Pages199
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.47 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.51 Billion
Compound Annual Growth Rate9.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Iron Drugs Market by Drug Type, Indication, Distribution Channel, End User, Formulation - Global Forecast to 2030 - Product Image

Iron Drugs Market by Drug Type, Indication, Distribution Channel, End User, Formulation - Global Forecast to 2030

  • Report
  • 181 Pages
  • Global
From
Intravenous Iron Drugs Market Size, Share, & Trends Analysis Report by Product (Iron Dextran, Iron Sucrose, Ferric Carboxymaltose), Application (Chronic Kidney Disease), and Region with Growth Forecasts, 2025-2030 - Product Image

Intravenous Iron Drugs Market Size, Share, & Trends Analysis Report by Product (Iron Dextran, Iron Sucrose, Ferric Carboxymaltose), Application (Chronic Kidney Disease), and Region with Growth Forecasts, 2025-2030

  • Report
  • 150 Pages
  • Global
From
Intravenous (IV) Iron Drugs - Global Strategic Business Report - Product Image

Intravenous (IV) Iron Drugs - Global Strategic Business Report

  • Report
  • 354 Pages
  • Global
From
Iron Drugs - Global Strategic Business Report - Product Image

Iron Drugs - Global Strategic Business Report

  • Report
  • 187 Pages
  • Global
From
Liposomal Iron Supplements Market by Product Type, Source, Application, Distribution Channel, End-User - Global Forecast to 2030 - Product Image

Liposomal Iron Supplements Market by Product Type, Source, Application, Distribution Channel, End-User - Global Forecast to 2030

  • Report
  • 181 Pages
  • Global
From

About the Intravenous Iron Market

The Intravenous Iron market is a segment of the Hematological Drugs market, which includes drugs used to treat anemia and other blood disorders. Intravenous Iron is a type of drug used to treat iron deficiency anemia, a condition in which the body does not have enough iron to produce healthy red blood cells. Intravenous Iron is administered directly into the bloodstream, allowing for a more rapid increase in iron levels than oral iron supplements. Intravenous Iron is used in a variety of settings, including hospitals, clinics, and home care. It is often prescribed to patients who are unable to take oral iron supplements due to gastrointestinal issues or who require a more rapid increase in iron levels. The Intravenous Iron market is highly competitive, with a number of companies offering products in this space. Some of the major players in the market include Vifor Pharma, Fresenius Kabi, American Regent, and B. Braun. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.